William Anderson Wittekind 13D and 13G filings for Renovaro Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-05-19 5:00 pm Purchase | 2022-04-15 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 5,301,478 10.000% | 5,301,478![]() (New Position) | Filing |
2023-05-19 5:00 pm Purchase | 2023-04-06 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,956,376 34.000% | 18,956,376![]() (New Position) | Filing |